Guelph, Canada

Laura Van Lieshout



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laura Van Lieshout: Innovator in Gene Therapy

Introduction

Laura Van Lieshout is a prominent inventor based in Guelph, Canada. She has made significant contributions to the field of gene therapy, particularly through her innovative work on adeno-associated virus (AAV) particles. Her research focuses on developing methods to deliver therapeutic agents effectively to various cells in the body.

Latest Patents

Laura holds a patent for an "Adeno-associated virus particle with mutated capsid and methods of use thereof." This patent describes a recombinant adeno-associated virus (rAAV) particle with a mutated capsid protein. The disclosure provides methods for delivering therapeutic agents to muscle, airway, liver, central nervous system, retina, or lung cells in a subject. Additionally, it outlines methods for treating or preventing infectious, acquired, or genetic diseases using the rAAV particle. She has 1 patent to her name.

Career Highlights

Throughout her career, Laura has worked with esteemed institutions such as the University of Guelph and the Ottawa Hospital Research Institute. Her work has been instrumental in advancing the understanding and application of gene therapy techniques.

Collaborations

Laura has collaborated with notable colleagues, including Sarah Wootton and Bernard Claude Frank Thebaud. These partnerships have contributed to her research and the successful development of her patented technologies.

Conclusion

Laura Van Lieshout is a trailblazer in the field of gene therapy, with her innovative approaches paving the way for new treatments. Her contributions to science and medicine continue to have a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…